Premarin
Sponsors
Dana-Farber Cancer Institute, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Wyeth is now a wholly owned subsidiary of Pfizer, GlaxoSmithKline, The Cleveland Clinic
Conditions
EstrogenEstrogen Replacement TherapyHealthyMenopausal and Female Climacteric StatesMenopauseOveractive BladderPelvic Floor DisordersPelvic Organ Prolapse
Phase 1
Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
CompletedNCT00318318
Start: 2006-03-31End: 2007-02-28Updated: 2009-07-09
Study Evaluating Premarin and Bazedoxifene Potential Interaction
CompletedNCT00745173
Start: 2008-09-30End: 2008-10-31Target: 30Updated: 2009-02-12
Phase 2
Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
CompletedNCT00134654
Start: 2003-03-31End: 2011-06-30Updated: 2011-06-16
Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)
CompletedNCT00604825
Start: 2007-07-17End: 2008-07-23Updated: 2017-10-03
Phase 4
Premarin Versus Toviaz for Treatment of Overactive Bladder
NCT01613170
Start: 2012-04-30End: 2018-12-31Target: 90Updated: 2017-04-20
Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor
CompletedNCT01778985
Start: 2012-12-31End: 2013-04-30Updated: 2014-10-02
Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
WithdrawnNCT02860897
Start: 2016-07-31End: 2017-07-31Updated: 2018-05-02